Description
Version-of-record in International Journal of Drug Policy
This commentary explores a recent shift in British Columbia's drug policy under a novel drug “decriminalization” framework. We focus on the province's move toward "recriminalization" under this framework. In short, recriminalization was a shift in BC's drug decriminalization ...
This commentary explores a recent shift in British Columbia's drug policy under a novel drug “decriminalization” framework. We focus on the province's move toward "recriminalization" under this framework. In short, recriminalization was a shift in BC's drug decriminalization framework to only apply in private residences, and be removed from essentially all outdoor spaces. This policy change was completed through an agreement with the federal government amid a public health emergency. Since 2016, BC has faced a severe crisis of drug-related overdoses and poisonings, driven by a toxic and unregulated drug supply compounded by prohibitionist policies. Expert recommendations for increasing access to a regulated drug supply have repeatedly dismissed as solutions by the governing BC New Democratic Party, opting instead for measures that do not undercut the toxic drug supply. We examine the sociolegal context of the BC government decision to recriminalize drug use in 2024, including attempts to criminalize recent drug use and police suspicion of substance use. These drug law reforms, understood here as forms of biopolitical violence, reflect a broader trend of using drug policies as tools for social and spatial regulation. By analyzing the sociolegal implications of these policies, the commentary situates the BC government's actions within a framework of sanctioned biopolitical massacre, highlighting the tension between purported decriminalization efforts and the actual enforcement strategies that perpetuate harm and exclusion. This examination underscores the complex interplay between drug policy, public health crises, and state power in the context of systemic colonial and racialized control that may be adaptable to other regions considering drug law reform.